Brown Melinda 4

What Happened
Melinda Brown, a director of Precision Biosciences, received an award of 20,979 restricted stock units (RSUs) on June 3, 2026. The RSUs were granted at $0.00 per unit (transaction code A), so there was no cash purchase or sale and no immediate change in share ownership value until vesting.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-05 (timely filing).
• Award: 20,979 RSUs granted at $0.00 per RSU (derivative award).
• Shares owned after transaction: not specified in the provided excerpt.
• Footnotes: (1) Each RSU represents a contingent right to one share of common stock. (2) RSUs vest on the earlier of June 3, 2027 or the day before the issuer's next annual meeting, subject to continued service.
• Transaction code: A = Award/Grant.

Context
RSUs are compensation that convert into actual shares only upon vesting; they do not represent immediate market purchases or sales and often reflect standard director or executive compensation. This grant does not by itself indicate buying or selling sentiment, as shares will only be issued (and potentially taxable) if and when the RSUs vest.